The BMI calculator does not determine eligibility for any weight loss medications or treatments provided via the Body Forward platform
Study-related adverse events In a 26-week, open-label study in adult patients (N=665) comparing Victoza 1.2 mg, Victoza 1.8 mg, and sitagliptin 100 mg, all in combination with metformin, the adverse reactions reported in 5% of patients treated with Victoza were nausea (23.9% vs 4.6%), headache (10.3% vs 10.0%), diarrhea (9.3% vs 4.6%), and vomiting (8.7% vs 4.1%)
Safety Signals, Side Effects, and Muscle Loss The most discussed retatrutide vs tirzepatide side effects are gastrointestinal
Gastroenterol Clinics North America
For individuals seeking support with weight management or metabolic health, NICE-appraised options are available through appropriate NHS or private channels